PAEDIATRICS

Not currently approved for paediatric use

ELDERLY

Limited data available on patients aged 65 years and older. Use in elderly should be cautious, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. No dose adjustments needed in patients aged 65 years and older.

PREGNANCY
NEW GLOBAL
GUIDELINES

Women with inflammatory bowel disease should discontinue etrasimod at least 1 to 2 weeks prior to conception unless there is no effective alternative therapy to maintain maternal health.17

BREASTFEEDING

Mothers currently on S1P receptor modulators should not breastfeed.17